207 related articles for article (PubMed ID: 25918247)
1. Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons.
Rauch I; Rosebrock F; Hainzl E; Heider S; Majoros A; Wienerroither S; Strobl B; Stockinger S; Kenner L; Müller M; Decker T
Mol Cell Biol; 2015 Jul; 35(13):2332-43. PubMed ID: 25918247
[TBL] [Abstract][Full Text] [Related]
2. Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9.
Li W; Hofer MJ; Songkhunawej P; Jung SR; Hancock D; Denyer G; Campbell IL
J Biol Chem; 2017 Apr; 292(14):5845-5859. PubMed ID: 28213522
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of Tetraodon nigroviridis Mx gene promoter activity by constitutively-active forms of STAT1, STAT2, and IRF9.
Cheng CH; Chou CM; Chu CY; Chen GD; Lien HW; Hwang PP; Chang MS; Huang CJ
Fish Shellfish Immunol; 2014 May; 38(1):230-43. PubMed ID: 24680831
[TBL] [Abstract][Full Text] [Related]
4. Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus.
Hofer MJ; Li W; Manders P; Terry R; Lim SL; King NJ; Campbell IL
J Virol; 2012 Jun; 86(12):6932-46. PubMed ID: 22496215
[TBL] [Abstract][Full Text] [Related]
5. STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1.
Blaszczyk K; Olejnik A; Nowicka H; Ozgyin L; Chen YL; Chmielewski S; Kostyrko K; Wesoly J; Balint BL; Lee CK; Bluyssen HA
Biochem J; 2015 Mar; 466(3):511-24. PubMed ID: 25564224
[TBL] [Abstract][Full Text] [Related]
6. A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription.
Platanitis E; Demiroz D; Schneller A; Fischer K; Capelle C; Hartl M; Gossenreiter T; Müller M; Novatchkova M; Decker T
Nat Commun; 2019 Jul; 10(1):2921. PubMed ID: 31266943
[TBL] [Abstract][Full Text] [Related]
7. Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication.
Poat B; Hazari S; Chandra PK; Gunduz F; Alvarez X; Balart LA; Garry RF; Dash S
Virol J; 2010 Oct; 7():265. PubMed ID: 20939906
[TBL] [Abstract][Full Text] [Related]
8. Expression regulation of zebrafish interferon regulatory factor 9 by promoter analysis.
Shi J; Zhang YB; Zhang JS; Gui JF
Dev Comp Immunol; 2013 Dec; 41(4):534-43. PubMed ID: 23916490
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of interferon regulatory factor 9 in the antiviral host response and beyond.
Suprunenko T; Hofer MJ
Cytokine Growth Factor Rev; 2016 Jun; 29():35-43. PubMed ID: 26987614
[TBL] [Abstract][Full Text] [Related]
10. Selective Interferon Responses of Intestinal Epithelial Cells Minimize Tumor Necrosis Factor Alpha Cytotoxicity.
Van Winkle JA; Constant DA; Li L; Nice TJ
J Virol; 2020 Oct; 94(21):. PubMed ID: 32847859
[TBL] [Abstract][Full Text] [Related]
11. The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9.
Hofer MJ; Li W; Lim SL; Campbell IL
J Neurosci; 2010 Jan; 30(3):1149-57. PubMed ID: 20089923
[TBL] [Abstract][Full Text] [Related]
12. The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses.
Blaszczyk K; Nowicka H; Kostyrko K; Antonczyk A; Wesoly J; Bluyssen HA
Cytokine Growth Factor Rev; 2016 Jun; 29():71-81. PubMed ID: 27053489
[TBL] [Abstract][Full Text] [Related]
13. Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs.
Abdul-Sater AA; Majoros A; Plumlee CR; Perry S; Gu AD; Lee C; Shresta S; Decker T; Schindler C
J Immunol; 2015 Jul; 195(1):210-216. PubMed ID: 26019270
[TBL] [Abstract][Full Text] [Related]
14. IFN-γ and IL-17A regulate intestinal crypt production of CXCL10 in the healthy and inflamed colon.
Walrath T; Malizia RA; Zhu X; Sharp SP; D'Souza SS; Lopez-Soler R; Parr B; Kartchner B; Lee EC; Stain SC; Iwakura Y; O'Connor W
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G479-G489. PubMed ID: 31790273
[TBL] [Abstract][Full Text] [Related]
15. Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency.
Gothe F; Stremenova Spegarova J; Hatton CF; Griffin H; Sargent T; Cowley SA; James W; Roppelt A; Shcherbina A; Hauck F; Reyburn HT; Duncan CJA; Hambleton S
J Allergy Clin Immunol; 2022 Oct; 150(4):955-964.e16. PubMed ID: 35182547
[TBL] [Abstract][Full Text] [Related]
16. Interaction of IRF9 and STAT2 synergistically up-regulates IFN and PKR transcription in Ctenopharyngodon idella.
Wu Z; Wang L; Xu X; Lin G; Mao H; Ran X; Zhang T; Huang K; Wang H; Huang Q; Xu Q; Hu C
Mol Immunol; 2017 May; 85():273-282. PubMed ID: 28347954
[TBL] [Abstract][Full Text] [Related]
17. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function.
Rengachari S; Groiss S; Devos JM; Caron E; Grandvaux N; Panne D
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E601-E609. PubMed ID: 29317535
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
[TBL] [Abstract][Full Text] [Related]
20. HCV NS5A and IRF9 compete for CypA binding.
Bobardt M; Hopkins S; Baugh J; Chatterji U; Hernandez F; Hiscott J; Sluder A; Lin K; Gallay PA
J Hepatol; 2013 Jan; 58(1):16-23. PubMed ID: 22902549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]